Launches its revolutionary antibiotic with highest purity - Purimox® from the DSM Pure Actives TM portfolio

Global leader DSM Anti-Infectives today announced the launch of its breakthrough technology in India, in succession to its first production facility in Spain with the introduction of Purimox® an antibiotic with highest purity. Speaking on the occasion of the introduction of Purimox®, Mr. Gerard De Reuver, President, DSM Anti-Infectives said, “We have a long-term commitment to India. DSM is proud to be in India, a country that has recognized the value and importance of a strong biomedical and pharmaceutical industry. We will follow DSM’s inherent commitment to its relentless pursuit of scientific excellence and innovation. India, over the years has become an important market with and the new plant is part of our expansion plans to have a strong footing in the region.’’

Purimox®, a penicillin based antibiotic, is from the DSM Pure ActivesTM family of environmental friendly products. Purimox® was introduced in Toansa, Punjab by Mr. Gerard De Reuver, the President of DSM Anti-Infectives. Conventionally, amoxicillin is produced in a synthetic process using strong solvents and chemicals.

Purimox® is a technological breakthrough as it produces amoxicillin in an enzymatic route without use of solvents, leading to a product of higher purity and lesser impurities. Through the launch of production of Purimox® in India, DSM is making available to the pharmaceutical companies in Asia-Pacific/Middle East/ Africa and therefore to consumers, a safe product made in an effective and sustainable way.

Mr. N.V. Ramanan, Vice President, DSM Anti-Infectives, added: “DSM’s continued and serious commitment to being a leader in the sector of anti-infectives has seen us continuously investing in breakthrough research to develop novel technologies. With the inauguration of this plant, we have strengthened the bond with our Asia Pacific, Middle East and African customers, providing them with a plant committed fully to the manufacturing of Purimox®. It is an antibiotic which will transfigure the standards of product purity leading to healthier and safer life.’’

DSM Anti-Infectives inaugurated the Purimox® plant at Toansa, Chandigarh, India which would be completely dedicated to the manufacturing of Purimox®. The plant would be dedicated to meet demand across Asia-Pacific, Middle East and Africa.

Fast Facts about Purimox®

• Environmentally friendly product
• Water based product with minimal chemical impurities
• Increases patient wellness

DSM India
Total turnover of DSM in India is $ 150 mn and currently as part of DSM’s strategy Vision 2010 – building on strengths it is engaged in a project to expand DSM’s operations in India.

DSM’s companies in India are engaged in a variety of social activities. To tackle malnutrition, DSM has started a humanitarian project by supplying capsules of Vitamin A. DSM Anti-Infectives also continuously participates in community welfare and developmental projects in and around Toansa where its plant is located. India is also the focus area of the base of the pyramid (BOP) activities that DSM is developing and promoting. DSM Anti-Infectives has also established a global sourcing operation, centered on emerging markets in India. As a demonstration of faith in India, they have established the Asia Pacific Middle East operations out of Gurgaon.